Key result
Preoperative clopidogrel in off-pump CABG is linked to increased bleeding and ~12-fold higher platelet transfusion risk.
Why the study?
Does preoperative clopidogrel increase bleeding and transfusions in patients undergoing off-pump CABG surgery?
Cohort (n=453)
Does preoperative clopidogrel increase bleeding and transfusions in patients undergoing off-pump CABG surgery?
Discontinuation of clopidogrel at least 72 hours prior to off-pump CABG surgery normalizes bleeding risk to that of patients not on clopidogrel.
Answers are grounded in this paper and cite their sources.
Supports bleeding risk consideration with preoperative clopidogrel in off-pump CABG; leaves optimal discontinuation timing open for randomized confirmation.
OBJECTIVE: The use of antiplatelet drugs to treat acute myocardial infarction, unstable angina, acute coronary syndrome and secondary prevention following percutaneous coronary interventions is well accepted. However, it constitutes a serious risk of bleeding for patients undergoing coronary artery bypass grafting surgery (CABG). We evaluated the effect of aspirin and clopidogrel (CPDG), both irreversible platelet aggregation inhibitors, on operative bleeding and determined the optimal timing for their discontinuation before surgery. METHOD: Between July 2001 and December 2004, we reviewed our experience with 453 patients undergoing off-pump CABG surgery (OPCAB) who received CPDG (n=101) or not (n=352) preoperatively, and compared the intraoperative and postoperative bleeding to determine risks factors associated with blood or platelet transfusions. RESULTS: Clopidogrel in OPCAB surgery is associated with higher intraoperative (702.24 ml vs 554.13 ml, p=0.03) and postoperative bleeding (864.93 ml vs 603.75 ml, p=0.03). The mean operative blood loss is higher in patients still on CPDG at the time of surgery compared to patients off CPDG at least 72 h before surgery (802 ml vs 554.13 ml, p<0.0001). Blood loss in the later subgroup of patients is comparable to the control group without CPDG (p=NS). Clopidogrel is associated with more platelet transfusions (OR=11.79, [1.48; 93.86]). CONCLUSION: Blood loss is higher in OPCAB patients receiving clopidogrel before surgery. However, discontinuation of clopidogrel three days (72 h) prior to the operation demonstrated a similar blood loss pattern compared to a control group. Clopidogrel is associated with more platelets, but not red blood cell transfusions following OPCAB surgery.
No takes yet. Share an insight, caveat, or question.
Maltais et al. (2008) conducted a cohort in Off-pump coronary artery bypass graft surgery (OPCAB) (n=453). Clopidogrel vs. No clopidogrel was evaluated on Intraoperative bleeding (ml) (p=0.03). Preoperative clopidogrel in off-pump CABG surgery was associated with higher intraoperative bleeding and increased risk of platelet transfusions.
Synapse has enriched 10 related papers. Consider them for comparative context: